Bruker Corporation (BRKR) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.

Total Revenue Chart for Bruker Corporation

Bruker Corporation (BRKR) revenue for FY2025 was USD 3.4B, a 2.1% change from FY2024. Bruker Corporation's revenue grew from USD 42.2M in 1998 to USD 3.4B in 2025 (8042.0% over 27 years). Earnings per share grew from USD 0.04 in 2000 to USD 1.99 in 2022 (5305.2%). Revenue compound annual growth rate: 5-year CAGR of 11.6%, 10-year CAGR of 7.8%, 20-year CAGR of 13.0%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$9.22B
Implied Share Price
$60.50
Enterprise Value
$10.69B
Revenue (TTM)
$3.50B
EBITDA
$541.10M
Profit Margin
-2.04%
Trailing P/E
—
Forward P/E
13.83
Price/Book (MRQ)
3.82
Price/Sales (TTM)
2.63
EV/EBITDA
39.72
EV/Revenue
3.06
Dividend Yield
0.31%
Book Value
$15.63
Free Cash Flow (FY2025)
$13.90M
Free Cash Flow Yield
0.15%

Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.